Floatz logo

Dkn-01

Colo-rectal Cancer

Leap Therapeutics, Inc.Phase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Colo-rectal Cancer cohort.

Asset / SponsorPhaseRating
Modufolin
Isofol Medical AB
Phase 3BB
Pentoxifylline
Tanta University
Phase 2BB
Montanide Isa 51
Roswell Park Cancer Institute
Phase 1/2CCC
Dalmitamig
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2CCC
vv1
Vyriad, Inc.
Phase 2CCC

View all 28 →

Same molecule, other indications

Dkn-01 is also rated in:

uterine cancerDormant
B
Indicative ·
57 / 100
View asset →
carcinosarcomaDormant
B
Indicative ·
57 / 100
View asset →
colorectal adenocarcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →